These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2030367)

  • 1. Intermittent long-term adrenocorticosteroid treatment of myasthenia gravis.
    Wakata N; Kawamura Y; Kobayashi M; Araki Y; Kinoshita M
    J Neurol; 1991 Feb; 238(1):16-8. PubMed ID: 2030367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Myasthenia gravis and steroid therapy].
    Wakata N; Nemoto H; Niizuma M; Araki Y; Kinoshita M
    Rinsho Shinkeigaku; 1992 Feb; 32(2):131-7. PubMed ID: 1611770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term prednisone followed by thymectomy in myasthenia gravis.
    Mann JD; Johns TR; Campa JF; Muller WH
    Ann N Y Acad Sci; 1976; 274():608-22. PubMed ID: 1066998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does perioperative high-dose prednisolone have clinical benefits for generalized myasthenia gravis?
    Sekine Y; Kawaguchi N; Hamada C; Sekiguchi H; Yasufuku K; Iyoda A; Shibuya K; Fujisawa T
    Eur J Cardiothorac Surg; 2006 Jun; 29(6):908-13. PubMed ID: 16675232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Thymectomy for the treatment of thymoma--concomitant administration of large doses of prednisolone on alternate days before and after the surgical procedure].
    Yamaguchi Y; Baba M; Shoman S; Kawano H; Ito N
    Rinsho Kyobu Geka; 1983 Jul; 3(4):437-43. PubMed ID: 6658312
    [No Abstract]   [Full Text] [Related]  

  • 6. Favorable results of thymectomy combined with prednisolone alternate-day administration in myasthenia gravis.
    Yamaguchi Y; Saito Y; Baba M; Obata S
    Jpn J Surg; 1987 Jan; 17(1):14-20. PubMed ID: 3573441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relapse of ocular symptoms after remission of myasthenia gravis--a comparison of relapsed and complete remission cases.
    Wakata N; Iguchi H; Sugimoto H; Nomoto N; Kurihara T
    Clin Neurol Neurosurg; 2003 Apr; 105(2):75-7. PubMed ID: 12691794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ocular myasthenia gravis: response to long-term immunosuppressive treatment.
    Sommer N; Sigg B; Melms A; Weller M; Schepelmann K; Herzau V; Dichgans J
    J Neurol Neurosurg Psychiatry; 1997 Feb; 62(2):156-62. PubMed ID: 9048716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized double-blind trial of prednisolone alone or with azathioprine in myasthenia gravis. Myasthenia Gravis Study Group.
    Palace J; Newsom-Davis J; Lecky B
    Neurology; 1998 Jun; 50(6):1778-83. PubMed ID: 9633727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experience with programmed steroid treatment with thymectomy in nonthymomatous myasthenia gravis.
    Endo S; Yamaguchi T; Saito N; Otani S; Hasegawa T; Sato Y; Sohara Y
    Ann Thorac Surg; 2004 May; 77(5):1745-50. PubMed ID: 15111178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term treatment of steroid-dependent myasthenia gravis patients with low-dose tacrolimus.
    Nagaishi A; Yukitake M; Kuroda Y
    Intern Med; 2008; 47(8):731-6. PubMed ID: 18421189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Long term administration of oral prednisone or prednisolone in treatment of myasthenia gravis. Report of five cases (author's transl)].
    Contamin F; Singer B; Mignot B; Offenstadt G; Ecoffet M
    Sem Hop; 1978 Nov 18-25; 54(41-42):1213-8. PubMed ID: 216096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of myasthenia gravis treated with steroids: some suggestions for the mechanisms underlying their effect.
    Dandona P; Corkan EJ; Sladen GE
    Postgrad Med J; 1977 Jun; 53(620):321-4. PubMed ID: 887530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myasthenia gravis and diabetes mellitus: a 35-year retrospective study.
    Wakata N; Nemoto H; Konno S; Nakazora H; Nomoto N; Sugimoto H; Kurihara T
    Intern Med; 2007; 46(9):557-9. PubMed ID: 17473488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of myasthenia gravis by long-term alternate-day prednisolone.
    Chen RC; Sung SM; Soong WT; Ryu SJ; Sun JL; Hung TP
    Taiwan Yi Xue Hui Za Zhi; 1975 Sep; 74(9):579-89. PubMed ID: 1062502
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of myasthenia gravis].
    Wakata N
    Rinsho Shinkeigaku; 1999 Dec; 39(12):1222-5. PubMed ID: 10791082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corticotropin and corticosteroids in generalized myasthenia gravis: comparative studies and role in management.
    Brunner NG; Berger CL; Namba T; Grob D
    Ann N Y Acad Sci; 1976; 274():577-95. PubMed ID: 183590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rationale for the clinical guidelines for myasthenia gravis in Japan.
    Murai H; Utsugisawa K; Nagane Y; Suzuki S; Imai T; Motomura M
    Ann N Y Acad Sci; 2018 Feb; 1413(1):35-40. PubMed ID: 29377151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A child with generalized myasthenia gravis successfully treated with tacrolimus].
    Goto T; Mori M; Yamagata T; Mizuguchi M; Momoi MY
    No To Hattatsu; 2007 Jul; 39(4):300-3. PubMed ID: 17633089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benefits of FK506 (tacrolimus) for residual, cyclosporin- and prednisone-resistant myasthenia gravis: one-year follow-up of an open-label study.
    Ponseti JM; Azem J; Fort JM; Codina A; Montoro JB; Armengol M
    Clin Neurol Neurosurg; 2005 Apr; 107(3):187-90. PubMed ID: 15823673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.